Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Targeting colon cancer stem cells might lead to better treatment results.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Keratins are crucial for cell structure, growth, and disease risk.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

Wrinkles form due to structural skin changes and vary in type and treatment response.

A WNT10A gene mutation leads to ectodermal dysplasia by disrupting cell growth and differentiation.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Skin diseases differ between Ghana and the UK, with infections most common in Ghana and malignant skin diseases most prevalent in the UK.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Aromatase gene variation may increase female hair loss risk.